N-(4-Bromo-phen-yl)-2-[(1-cyclo-hexyl-meth-yl-1H-1,2,4-triazol-3-yl)sulfanyl]-acetamide.
Acta Crystallogr Sect E Struct Rep Online
; 68(Pt 5): o1495, 2012 May 01.
Article
em En
| MEDLINE
| ID: mdl-22590366
ABSTRACT
The title compound, C(17)H(21)BrN(4)OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N-Hâ¯S hydrogen bond making a five-membered ring. In the crystal, mol-ecules are connected into centrosymmetric dimers via pairs of N-Hâ¯N and weak C-Hâ¯N hydrogen bonds. The crystal structure also features C-Hâ¯O inter-actions.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article